Indications for: VYZULTA

Open-angle glaucoma. Ocular hypertension.

Adult Dosage:

>16yrs: instill 1 drop in the affected eye(s) once daily in the PM.

Children Dosage:

≤16yrs: not recommended.

VYZULTA Warnings/Precautions:

Do not exceed recommended dose (may reduce efficacy). History of ocular inflammation: not recommended if active inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Bacterial keratitis may occur (due to multiple-dose containers). Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

VYZULTA Classification:

Prostaglandin analogue.

VYZULTA Interactions:

Allow at least 5mins between application of other topical oph agents.

Adverse Reactions:

Conjunctival hyperemia, eye irritation, eye pain, instillation site pain; increased ocular pigmentation (eg, iris [may be permanent], eyelid, eyelashes), other eyelash/lid changes, macular edema (including cystoid macular edema).

Generic Drug Availability:


How Supplied: